Corcept Therapeutics CORT
NASDAQ CORT
$114.74 -0.89 (-0.77%)
At close: Sep 29, 2026 · 4:00 PM EDT

Corcept Therapeutics (CORT) Share-based Compensation (IS) (2010)

Updated

Corcept Therapeutics (CORT) recorded Share-based Compensation (IS) of $585,000 in Q4 2010, up 7.3% from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Share-based Compensation (IS) (2010) Analysis & Trends

For FY2010, Corcept Therapeutics reported Share-based Compensation (IS) of $2.12 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Corcept Therapeutics 12.50 Bn 11.06 Bn 252.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 585,000.00
Sep 30, 2010 545,000.00
Jun 30, 2010 502,000.00
API Access

Corcept Therapeutics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=CORT&period=max&api_key=YOUR_API_KEY